These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1280 related articles for article (PubMed ID: 10598751)

  • 21. Twenty years of metabonomics: so what has metabonomics done for toxicology?
    Griffin JL
    Xenobiotica; 2020 Jan; 50(1):110-114. PubMed ID: 31826699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosing-Time Makes the Poison: Circadian Regulation and Pharmacotherapy.
    Dallmann R; Okyar A; Lévi F
    Trends Mol Med; 2016 May; 22(5):430-445. PubMed ID: 27066876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biosimulation of drug metabolism--a yeast based model.
    Pieper I; Wechler K; Katzberg M; Brusch L; Sørensen PG; Mensonides F; Bertau M
    Eur J Pharm Sci; 2009 Jan; 36(1):157-70. PubMed ID: 19041718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Importance of the metabolic oxidation of drugs and other xenobiotics: recent developments].
    Fleury MB
    Ann Pharm Fr; 2011 Jan; 69(1):1-2. PubMed ID: 21296211
    [No Abstract]   [Full Text] [Related]  

  • 25. Predicting drug side-effects by chemical systems biology.
    Tatonetti NP; Liu T; Altman RB
    Genome Biol; 2009; 10(9):238. PubMed ID: 19723347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug discovery projects. Preface.
    Lawton G; Witty DR
    Prog Med Chem; 2011; 50():v-vi. PubMed ID: 21476319
    [No Abstract]   [Full Text] [Related]  

  • 27. Biotransformation and excretion: in vivo studies utilizing stable isotopes and nuclear magnetic resonance.
    Unkefer CJ
    J Clin Pharmacol; 1986; 26(6):452-8. PubMed ID: 3734136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arylamine N-acetyltransferases and drug response.
    Meisel P
    Pharmacogenomics; 2002 May; 3(3):349-66. PubMed ID: 12052143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nutritional metabonomics: applications and perspectives.
    Rezzi S; Ramadan Z; Fay LB; Kochhar S
    J Proteome Res; 2007 Feb; 6(2):513-25. PubMed ID: 17269708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drugs in control samples in nonclinical safety studies: a reconsideration.
    Zimmer D
    Bioanalysis; 2016 May; 8(10):1003-7. PubMed ID: 27080047
    [No Abstract]   [Full Text] [Related]  

  • 31. Cometabolism of microbes and host: implications for drug metabolism and drug-induced toxicity.
    Li H; Jia W
    Clin Pharmacol Ther; 2013 Nov; 94(5):574-81. PubMed ID: 23933971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of biotransformation in conceptal toxicity of drugs and other chemicals.
    Kulkarni AP
    Curr Pharm Des; 2001 Jun; 7(9):833-57. PubMed ID: 11375781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism of drugs and other xenobiotics in the gut lumen and wall.
    Ilett KF; Tee LB; Reeves PT; Minchin RF
    Pharmacol Ther; 1990; 46(1):67-93. PubMed ID: 2181492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabonomics in pharmaceutical R&D.
    Lindon JC; Holmes E; Nicholson JK
    FEBS J; 2007 Mar; 274(5):1140-51. PubMed ID: 17298438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of drug metabolites.
    Izumi T
    Drug Metab Pharmacokinet; 2011; 26(2):121-2. PubMed ID: 21532211
    [No Abstract]   [Full Text] [Related]  

  • 36. The role of transporters in toxicity and disease.
    Schuetz JD; Swaan PW; Tweedie DJ
    Drug Metab Dispos; 2014 Apr; 42(4):541-5. PubMed ID: 24598705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of biomarkers to diagnose diseases and find adverse drug reactions by metabolomics.
    Saigusa D; Matsukawa N; Hishinuma E; Koshiba S
    Drug Metab Pharmacokinet; 2021 Apr; 37():100373. PubMed ID: 33631535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioactivation of drugs: risk and drug design.
    Walsh JS; Miwa GT
    Annu Rev Pharmacol Toxicol; 2011; 51():145-67. PubMed ID: 21210745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Types of stereoselectivity in drug metabolism: a heuristic approach.
    Testa B
    Drug Metab Rev; 2015 May; 47(2):239-51. PubMed ID: 25410915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mechanisms of drug metabolism--implications for drug interaction].
    Sitkiewicz D
    Pol Merkur Lekarski; 2000 Sep; 9(51):595-7. PubMed ID: 11126981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 64.